scholarly journals A supramolecular assembly formed by influenza A virus genomic RNA segments

2011 ◽  
Vol 40 (5) ◽  
pp. 2197-2209 ◽  
Author(s):  
Emilie Fournier ◽  
Vincent Moules ◽  
Boris Essere ◽  
Jean-Christophe Paillart ◽  
Jean-Daniel Sirbat ◽  
...  
Vaccine ◽  
2012 ◽  
Vol 30 (51) ◽  
pp. 7359-7367 ◽  
Author(s):  
Emilie Fournier ◽  
Vincent Moules ◽  
Boris Essere ◽  
Jean-Christophe Paillart ◽  
Jean-Daniel Sirbat ◽  
...  

2021 ◽  
pp. 101245
Author(s):  
Marta Soszynska-Jozwiak ◽  
Maciej Pszczola ◽  
Julita Piasecka ◽  
Jake M. Peterson ◽  
Walter N. Moss ◽  
...  

2006 ◽  
Vol 80 (1) ◽  
pp. 252-261 ◽  
Author(s):  
John F. Regan ◽  
Yuying Liang ◽  
Tristram G. Parslow

ABSTRACT The RNA-dependent RNA polymerase of influenza A virus is composed of three subunits that together synthesize all viral mRNAs and also replicate the viral genomic RNA segments (vRNAs) through intermediates known as cRNAs. Here we describe functional characterization of 16 site-directed mutants of one polymerase subunit, termed PA. In accord with earlier studies, these mutants exhibited diverse, mainly quantitative impairments in expressing one or more classes of viral RNA, with associated infectivity defects of varying severity. One PA mutant, however, targeting residues 507 and 508, caused only modest perturbations of RNA expression yet completely eliminated the formation of plaque-forming virus. Polymerases incorporating this mutant, designated J10, proved capable of synthesizing translationally active mRNAs and of replicating diverse cRNA or vRNA templates at levels compatible with viral infectivity. Both the mutant protein and its RNA products were appropriately localized in the cytoplasm, where influenza virus assembly occurs. Nevertheless, J10 failed to generate infectious particles from cells in a plasmid-based influenza virus assembly assay, and hemagglutinating material from the supernatants of such cells contained little or no nuclease-resistant genomic RNA. These findings suggest that PA has a previously unrecognized role in assembly or release of influenza virus virions, perhaps influencing core structure or the packaging of vRNAs or other essential components into nascent influenza virus particles.


PLoS ONE ◽  
2016 ◽  
Vol 11 (2) ◽  
pp. e0148281 ◽  
Author(s):  
Elzbieta Lenartowicz ◽  
Julita Kesy ◽  
Agnieszka Ruszkowska ◽  
Marta Soszynska-Jozwiak ◽  
Paula Michalak ◽  
...  

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Paula Michalak ◽  
Marta Soszynska-Jozwiak ◽  
Ewa Biala ◽  
Walter N. Moss ◽  
Julita Kesy ◽  
...  

2013 ◽  
Vol 110 (41) ◽  
pp. 16604-16609 ◽  
Author(s):  
C. Gavazzi ◽  
M. Yver ◽  
C. Isel ◽  
R. P. Smyth ◽  
M. Rosa-Calatrava ◽  
...  

mBio ◽  
2010 ◽  
Vol 1 (4) ◽  
Author(s):  
Jennifer L. Umbach ◽  
Hui-Ling Yen ◽  
Leo L. M. Poon ◽  
Bryan R. Cullen

ABSTRACTEvidence has recently accumulated suggesting that small noncoding RNAs, and particularly microRNAs, have the potential to strongly affect the replication and pathogenic potential of a range of human virus species. Here, we report the use of deep sequencing to comprehensively analyze small viral RNAs (18 to 27 nucleotides [nt]) produced during infection by influenza A virus. Although influenza A virus differs from most other RNA viruses in that it replicates its genome in the nucleus and is therefore exposed to the nuclear microRNA processing factors Drosha and DGCR8, we did not observe any microRNAs encoded by influenza virus genes. However, influenza virus infection did induce the expression of very high levels—over 100,000 copies per cell by 8 h postinfection—of a population of 18- to 27-nt small viral leader RNAs (leRNAs) that originated from the precise 5′ ends of all eight influenza virus genomic RNA (vRNA) segments. Like the vRNAs themselves, our data indicate that the leRNAs also bear a 5′-terminal triphosphate and are therefore not capable of functioning as microRNAs. Instead, the high-level production of leRNAs may imply a role in another aspect of the viral life cycle, such as regulation of the switch from viral mRNA transcription to genomic RNA synthesis.IMPORTANCEInfluenza A virus is an important human pathogen that has the potential to give rise to serious pandemics. Here, we demonstrate that influenza A virus induces the expression of very high levels of small viral leader RNAs (leRNAs) within hours of infection. These RNAs are unusual in that they bear a 5′ triphosphate and originate from the very 5′ ends of the eight viral genomic RNA (vRNA) segments. Their high expression may imply an important role in the viral life cycle that could potentially serve as a novel target for antiviral drugs.


2016 ◽  
Vol 20 (5) ◽  
pp. 674-681 ◽  
Author(s):  
Roshan J. Thapa ◽  
Justin P. Ingram ◽  
Katherine B. Ragan ◽  
Shoko Nogusa ◽  
David F. Boyd ◽  
...  

2021 ◽  
Vol 22 (17) ◽  
pp. 9127
Author(s):  
Yuki Furuse

Recent studies about the transcriptome-wide presence of RNA modifications have revealed their importance in many cellular functions. Nevertheless, information about RNA modifications in viral RNA is scarce, especially for negative-strand RNA viruses. Here we provide a catalog of RNA modifications including m1A, ac4C, m7G, inosine, and pseudouridine on RNA derived from an influenza A virus infected into A549 cells, as studied by RNA immunoprecipitation followed by deep-sequencing. Possible regions with RNA modifications were found in the negative-strand segments of viral genomic RNA. In addition, our analyses of previously published data revealed that the expression levels of the host factors for RNA modifications were affected by an infection with influenza A virus, and some of the host factors likely have a proviral effect. RNA modification is a novel aspect of host–virus interactions leading to the discovery of previously unrecognized viral pathogenicity mechanisms and has the potential to aid the development of novel antivirals.


Planta Medica ◽  
2012 ◽  
Vol 78 (11) ◽  
Author(s):  
A Derksen ◽  
W Hafezi ◽  
A Hensel ◽  
J Kühn

Sign in / Sign up

Export Citation Format

Share Document